Further, OTC1 levels were not found to be statistically significant in patients with NASH versus steatosis simple patients or versus healthy controls (1.9 × 105 ± 1.4 × 104vs. 1.6 × 105 ± 1.7 × 105 or vs. 2.8 × 105 ± 1.1 × 105 positive pixels, p = ns) (Fig. 2C). Here, OTC is linked to metabolic dysfunction-associated steatohepatitis.